P

Inventor

SHIVELY JOHN E

US26 patents
⚠️ This page may combine multiple inventors who share the name “SHIVELY JOHN E”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

HOPE CITY

20 patents
US7776330B2Aug 17, 2010

Humanized anti-CEA T84.66 antibody and uses thereof

HOPE CITY25 citations90
US5081235AJan 14, 1992

Chimeric anti-cea antibody

HOPE CITY40 citations90
US5075431ADec 24, 1991

Chimeric anti-CEA antibody

HOPE CITY25 citations90
US7273608B2Sep 25, 2007

Humanized anti-CEA T84.66 antibody and uses thereof

HOPE CITY10 citations82
US5137695AAug 11, 1992

Apparatus for the sequential performance of chemical processes

HOPE CITY21 citations77
US5861125AJan 19, 1999

Protein or peptide sequencing method and apparatus

HOPE CITY12 citations73
US5061635AOct 29, 1991

Protein or peptide sequencing method

HOPE CITY6 citations73
US5432092AJul 11, 1995

C-terminal peptide sequencing using diphenyl phosphoroisothiocyanatidate and pyridine

HOPE CITY13 citations72
US5180807AJan 19, 1993

C-terminal peptide or protein sequencing reagent and method

HOPE CITY14 citations72
US5432093AJul 11, 1995

Sequential degradation of proteins and peptides from the N-terminus

HOPE CITY6 citations61
US5432091AJul 11, 1995

N-terminal sequencing of proteins and peptides

HOPE CITY4 citations61
US11541062B2Jan 3, 2023

Methods of treating advanced prostate cancer

HOPE CITY0 citations60
US10603328B2Mar 31, 2020

Methods of treating advanced prostate cancer

HOPE CITY1 citations60
US5227309AJul 13, 1993

C-terminal peptide sequencing method

HOPE CITY5 citations57
US12043673B2Jul 23, 2024

Complementary RNA linked bispecific T-cell engaging antibodies

HOPE CITY0 citations55
US5998213ADec 7, 1999

C-terminal sequencing of peptides which may include proline

HOPE CITY0 citations51
US5986071ANov 16, 1999

Method for C-terminal degradation of peptides and proteins

HOPE CITY1 citations51
US5541114AJul 30, 1996

Sequencing of protein immobilized on polytetrafluoroethylene supports

HOPE CITY1 citations51
US5525707AJun 11, 1996

N-terminal peptide degradation utilizing dialkylthiocarbamoylhalides

HOPE CITY0 citations51
US9005969B2Apr 14, 2015

Generation of novel bone forming cells (monoosteophils) from LL-37 treated monocytes

HOPE CITY0 citations48

WU ANNA M

2 patents

BECKMAN RESEARCH INST OF CITY

1 patent

LOS ALAMOS NAT SECURITY LLC

1 patent

ZHANG ZHIFANG

1 patent

UNIV OF SOUTHERN CALIFORNIA USC STEVENS

1 patent